Authors: I. P. Romanova, A. V. Kazakov, S. P. Oleynikova, I. V. Chernyavskaya, E. G. Dorosh
SI «V. Danilevsky Institute of Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv
This research conducted the effect on the application of a new drug for the treatment of diabetic polyneuropathy in patients with types 1 and 2 diabetes. Established a positive influence on the hemodynamic, metabolic, biochemical parameters. Improved sensory-motor conduction in nerve fibers.
Key words: diabetes mellitus, diabetic polyneuropathy, treatment, Kokarnit.